Xi'an International Medical unveils capital raise, three-year shareholder return plan

Xi'an International Medical Investment plans a targeted share issuance for 2025 to raise up to 1.007 billion yuan, with funds allocated to a smart eldercare project (637.6 million yuan), a proton therapy center (99.9 million yuan), and working capital (270 million yuan). This initiative aims to strengthen the company’s capital structure, reduce asset-liability ratios from 68.80% in September 2025, and enhance core competitiveness in medical services.

The company's board has also approved a shareholder return plan for 2025-2027, prioritizing cash dividends when conditions are met, such as annual profitability and a positive accumulated distributable profit. This plan aligns with regulatory requirements, ensuring a minimum cumulative cash dividend of 30% of the average distributable profit over the last three years.

Shareholders will convene on December 19, 2025, to vote on the proposed share issuance and the three-year shareholder return plan. The company emphasizes robust corporate governance and diligent management of new capital to mitigate the dilutive impact on immediate returns.